CYTOSTATIC EFFECTS AND MECHANISMS OF ACTION OF BACTERIAL LECTIN OF BACILLUS SUBTILIS IMV B-7724 ON BREAST CANCER CELL LINES OF DIFFERENT MOLECULAR SUBTYPES

Authors

  • Ye. Lukianova R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the NAS of Ukraine, Kyiv, Ukraine
  • O. Mushii R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the NAS of Ukraine, Kyiv, Ukraine
  • V. Bazas Kyiv City Clinical Oncology Center, Kyiv, Ukraine
  • O. Voronina R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the NAS of Ukraine, Kyiv, Ukraine
  • N. Cheremshenko R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, the NAS of Ukraine, Kyiv, Ukraine

DOI:

https://doi.org/10.15407/exp-oncology.2025.03.277

Keywords:

lectin, breast cancer, molecular subtype

Abstract

Background. Lectins are carbohydrate-binding proteins with diverse biological activities, and they are increasingly recognized for their potential in cancer diagnostics and therapy. Aim of the study was to investigate the cytostatic and cytotoxic effects of the bacterial lectin of Bacillus subtilis IMV B-7724 on breast cancer (BC) cell lines of different molecular subtypes. Materials and Methods. Experiments were performed on the T47D (luminal A), MCF‑ 7 (luminal B), and MDA-MB-468 (basal, triple-negative) cell lines. Cytotoxicity was assessed by crystal violet staining and LC₅₀/LC₃₀ determination. Cytomorphological alterations were analyzed using the Romanowsky — Giemsa staining and ImageJ morphometry. A flow cytometry was applied to evaluate the cell cycle distribution and apoptosis (Annexin V/PI assay). The expression of proliferation and apoptosis regulators (Ki-67, p53, BCL-2, BAX) was examined by immunocytochemistry. Results. The lectin exerted dose-dependent cytotoxicity across all tested cell lines, with LC₅₀ values ranging between 351—419 μg/mL. The morphological analysis revealed subtype-specific alterations, including cell rounding, nuclear condensation, and decreased cytoplasmic volume, indicative of the apoptotic process. The flow cytometry showed distinct cell cycle arrest patterns: S-phase accumulation in T47D, G2/M blockade in MCF‑ 7, and combined S- and G2/M-phase arrest in MDA-MB-468. The viability assays confirmed a significant reduction of live cells, predominantly through late apoptosis and necrosis, with the strongest effect observed in T47D cells. The immunocytochemistry demonstrated a marked downregulation of Ki-67 and BCL-2, increased p53 expression, and BAX upregulation in MCF‑ 7 cells, whereas T47D cells displayed a paradoxical BAX suppression despite the apoptotic features. Conclusions. Lectin of B. subtilis IMV B-7724 exerts multifaceted effects on BC cells of different molecular subtypes, including the suppression of cell proliferation, activation of apoptosis, and cell cycle modulation. The observed differences between the BC cell lines suggest that the lectin efficacy depends on both the molecular profile of the cells and the mode of apoptosis regulation (p53-dependent or p53-independent), warranting further studies to identify key targets.

References

Barre A, Bourne y, Van damme EJM, Rougé P. Overview of the structure-function relationships of mannose-specific lectins from plants, algae and fungi. Int J Mol Sci. 2019;20(2):254. https://doi.org/10.3390/ijms20020254

Dias Rde O, Machado Ldos S, Migliolo L, franco OL. Insights into animal and plant lectins with antimicrobial activi- ties. Molecules. 2015;20(1):519-541. https://doi.org/10.3390/molecules20010519

Čaval T, Alisson-Silva f, Schwarz f. Roles of glycosylation at the cancer cell surface: opportunities for large scale glycoproteomics. Theranostics. 2023;13(8):2605-2615. https://doi.org/10.7150/thno.81760

Thomas d, Rathinavel AK, Radhakrishnan P. Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188464. https://doi.org/10.1016/j.bbcan.2020.188464

Yamashita K, Kuno A, Matsuda A, et al. Lectin microarray technology identifies specific lectins related to lymph node metastasis of advanced gastric cancer. Gastric Cancer. 2016;19(2):531-542. https://doi.org/10.1007/s10120- 015-0491-2

Na h, Liu X, Li X, et al. Novel roles of dC-SIGNR in colon cancer cell adhesion, migration, invasion, and liver metastasis. J Hematol Oncol. 2017;10(1):28. https://doi.org/10.1186/s13045-016-0383-x

Yin S, Li C, Shen X, et al. Siglec-G suppresses Cd8+ T Cells responses through metabolic rewiring and can be targeted to enhance tumor immunotherapy. Adv Sci (Weinh). 2024;11(45):e2403438. https://doi.org/10.1002/ advs.202403438

Rosato f, Pasupuleti R, Tomisch J, et al. A bispecific, crosslinking lectibody activates cytotoxic T cells and induces cancer cell death. J Transl Med. 2022;20(1):578. https://doi.org/10.1186/s12967-022-03794-w

Zhang C, Schumacher KN, dodds Ed, hage dS. Glycoprotein analysis using lectin microcolumns and capillary electrophoresis: сharacterization of alpha1-acid glycoprotein by combined separation methods. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1179:122855. https://doi.org/10.1016/j.jchromb.2021.122855

Zou X, yoshida M, Nagai-Okatani C, et al. A standardized method for lectin microarray-based tissue glycome mapping. Sci Rep. 2017;7:43560. https://doi.org/10.1038/srep43560

Devi RV, Basil-Rose MR. Lectins as Ligands for directing nanostructured systems. Curr Drug Deliv. 2018;15(4):448- 452. https://doi.org/10.2174/1567201815666180108101246

Meléndez AV, Velasco Cárdenas RM, Lagies S, et al. Novel lectin-based chimeric antigen receptors target Gb3- positive tumour cells. Cell Mol Life Sci. 2022;79(10):513. https://doi.org/10.1007/s00018-022-04524-7

Pasupuleti R, Riedl S, Saltor Núñez L, et al. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell- selective cytotoxic effect and inspires the production of «clickable» anticancer peptide in Escherichia coli. Protein Sci. 2023;32(12):e4830. https://doi.org/10.1002/pro.4830

Kuroda y, Oda T, Shimomura O, et al. Lectin-based phototherapy targeting cell surface glycans for pancreatic can- cer. Int J Cancer. 2023;152(7):1425-1437. https://doi.org/10.1002/ijc.34362

Chekhun Vf, didenko GV, Cheremshenko NL, et al. Strain of bacteria Bacillus subtilis ІMB В-7724 — producer of cytotoxic substances with antitumor activity (Pat. №131824 UA). Publ. 25.01.2019. Bul. №2. fedosova NI, Cherem- shenko NL, hetman KI, et al. Physicochemical and cytotoxicity properties of Bacillus subtilis ІМV В-7724 extracel- lular lectin. Mikrobiol Z. 2021;83:39-48. https://doi.org/10.15407/microbiolj83.01.039

Fedosova NI, Cheremshenko NL, hetman KI, et al. Physicochemical and cytotoxicity properties of Bacillus subtilis

ІМV В-7724 extracellular lectin. Mikrobiol Z. 2021;83:39-48. https://doi.org/10.15407/microbiolj83.01.039

Podgorsky VS. The method for the obtainment of bacterial lectin, specific to sialic acids (Pat. № 1791 UA). Publ. 23.01.1991. Bul. №1.

Chekhun S, Bezdenezhnykh N, Shvets J, Lukianova N. Expression of biomarkers related to cell adhesion, metastasis and invasion of breast cancer cell lines of different molecular subtype. Exp Oncol. 2013;35(3):174-179.

Chekhun SV, Lukyanova Ny, Shvets yV, et al. Significance of ferritin expression in formation of malignant pheno- type of human breast cancer cells. Exp Oncol. 2014;36(3):179-183.

feoktistova M, Geserick P, Leverkus M. Crystal Violet Assay for determining viability of cultured cells. Cold Spring Harb Protoc. 2016;2016(4):pdb.prot087379. https://doi.org/10.1101/pdb.prot087379

Wittekind dh. On the nature of Romanowsky — Giemsa staining and its significance for cytochemistry and histo- chemistry: an overall view. Histochem J. 1983;15(10):1029-1047. https://doi.org/10.1007/Bf01002498

Lukianova N, Zadvornyi T, Kashuba E, et al. Expression of markers of bone tissue remodeling in breast cancer and prostate cancer cells in vitro. Exp Oncol. 2022;44(1):39-46. https://doi.org/10.32471/exp-oncology.2312-8852.vol- 44-no-1.17354

Chekhun V, Pavlova A, Zadvornyi T, et al. Expression of SPP1 and SPARC genes in tumor tissue of patients with breast cancer. Exp Oncol. 2024;46(1):13-21. https://doi.org/10.15407/exp-oncology.2024.01.013

Hollestelle A, et al. distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines.

Breast Cancer Res Treat. 2010;121(1):53-64. https://doi.org/10.1007/s10549-009-0460-8

Lim Ly, Vidnovic N, Ellisen LW, Leong CO. Mutant p53 mediates survival of breast cancer cells. Br J Cancer. 2009;101(9):1606-1612. https://doi.org/10.1038/sj.bjc.6605335

Stathopoulos GP, Malamos NA, Markopoulos C, et al. The role of Ki-67 in the proliferation and prognosis of breast cancer molecular classification subtypes. Anticancer Drugs. 2014;25(8):950-957. https://doi.org/10.1097/ CAd.0000000000000123

Terävä J, Verhassel A, Botti O, et al. Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum. Cancer Rep (Hoboken). 2022;5(8):e1540. https://doi.org/10.1002/cnr2.1540

Lomonosova E, Ryerse J, Chinnadurai G. BAX/BAK-independent mitoptosis during cell death induced by protea- some inhibition? Mol Cancer Res. 2009;7(8):1268-1284. https://doi.org/10.1158/1541-7786.MCR-08-0183

Vousden Kh, Prives C. Blinded by the light: the growing complexity of p53. Cell. 2009;137(3):413-431. https://doi. org/10.1016/j.cell.2009.04.037

Downloads

Published

30.12.2025

How to Cite

Lukianova, Y., Mushii, O., Bazas, V., Voronina, O., & Cheremshenko, N. (2025). CYTOSTATIC EFFECTS AND MECHANISMS OF ACTION OF BACTERIAL LECTIN OF BACILLUS SUBTILIS IMV B-7724 ON BREAST CANCER CELL LINES OF DIFFERENT MOLECULAR SUBTYPES. Experimental Oncology, 47(3), 277–287. https://doi.org/10.15407/exp-oncology.2025.03.277

Issue

Section

Original contributions